Description

Ethyl 6,8-Dibromo-5-Methylimidazo-[1,2-A]Pyridine-2-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its specific halogenated imidazopyridine structure. This compound is of significant value for its role as a key building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly in medicinal chemistry research and development. It is primarily sought by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries for constructing novel heterocyclic compounds with potential biological activity.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, especially those targeting neurological or infectious diseases.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Agrochemical Synthesis: Serves as a building block for developing new pesticides or herbicides, leveraging its halogenated heterocyclic core.
• Fine Chemical Production: Employed in the custom synthesis of specialty chemicals for advanced material science applications.
• Academic & Contract Research: Utilized in university and CRO (Contract Research Organization) laboratories for methodological development and novel compound exploration.

Basic Information

Product Name	Ethyl 6,8-Dibromo-5-Methylimidazo-[1,2-A]Pyridine-2-Carboxylate
CAS No.	859787-43-2
Molecular Formula	C11H9Br2N3O2
Molecular Weight	375.01 g/mol
Synonyms	Ethyl 6,8-dibromo-5-methylimidazo[1,2-a]pyridine-2-carboxylate; 6,8-Dibromo-5-methylimidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester; Imidazo[1,2-a]pyridine-2-carboxylic acid, 6,8-dibromo-5-methyl-, ethyl ester; 859787-43-2; DBMPC; Ethyl 5-methyl-6,8-dibromoimidazo[1,2-a]pyridine-2-carboxylate
EINECS	Contact for details

Quality Control

Our Ethyl 6,8-Dibromo-5-Methylimidazo-[1,2-A]Pyridine-2-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical specifications. Our quality commitment ensures the material meets the stringent requirements for pharmaceutical R&D and cGMP intermediate production.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The container should be kept tightly sealed in a dry environment to minimize exposure to moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.